Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2021

01.01.2021 | Original Article

Circ_PGPEP1 Serves as a Sponge of miR-1297 to Promote Gastric Cancer Progression via Regulating E2F3

verfasst von: Yingxin Wang, Xia Liu, Liwei Wang, Zhenduo Zhang, Zhong Li, Ming Li

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Circular RNA (circRNA) is a special kind of noncoding RNA that plays a vital function in the progression of gastric cancer (GC). However, the role of a new circRNA, circ_PGPEP1, in GC is unclear.

Aims

Exploring the role and mechanism of circ_PGPEP1 in GC progression.

Methods

The expression levels of circ_PGPEP1, miR-1297, and E2F transcription factor 3 (E2F3) were determined using quantitative real-time PCR. Flow cytometry, colony formation assay, MTT assay, and transwell assay were used to evaluate cell cycle, apoptosis, proliferation, migration, and invasion. The protein levels of apoptosis-related markers and E2F3 were measured by western blot analysis. The interaction between circ_PGPEP1 and miR-1297 or miR-1297 and E2F3 was confirmed by dual-luciferase reporter assay. In addition, animal experiments were performed to assess the effect of circ_PGPEP1 on GC tumor growth in vivo.

Results

Circ_PGPEP1 was a highly expressed circRNA in GC. Loss-of-function experiment indicated that circ_PGPEP1 silencing could induce cell cycle arrest and apoptosis, while inhibit proliferation, migration, and invasion in GC cells. MiR-1297 could be sponged by circ_PGPEP1, and its expression was downregulated in GC. MiR-1297 inhibitor could reverse the negatively regulation of circ_PGPEP1 knockdown on GC progression. Furthermore, we also found that E2F3 could be targeted by miR-1297, and its expression was positively regulated by circ_PGPEP1. Overexpression of E2F3 could invert the inhibitory effect of miR-1297 on GC progression. Animal experiments suggested that silenced circ_PGPEP1 could reduce GC tumor growth.

Conclusion

Our research showed that circ_PGPEP1 might serve as a potential biomarker for GC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat den Hoed CM, Kuipers EJ. Gastric cancer: how can we reduce the incidence of this disease? Curr Gastroenterol Rep. 2016;18:34.CrossRef den Hoed CM, Kuipers EJ. Gastric cancer: how can we reduce the incidence of this disease? Curr Gastroenterol Rep. 2016;18:34.CrossRef
2.
Zurück zum Zitat Venerito M, Link A, Rokkas T, Malfertheiner P. Gastric cancer—clinical and epidemiological aspects. Helicobacter. 2016;21 Suppl 1:39–44.CrossRef Venerito M, Link A, Rokkas T, Malfertheiner P. Gastric cancer—clinical and epidemiological aspects. Helicobacter. 2016;21 Suppl 1:39–44.CrossRef
3.
Zurück zum Zitat Feingold PL, Kwong ML, Davis JL, Rudloff U. Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: a systematic review. J Surg Oncol. 2017;115:192–201.CrossRef Feingold PL, Kwong ML, Davis JL, Rudloff U. Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: a systematic review. J Surg Oncol. 2017;115:192–201.CrossRef
4.
Zurück zum Zitat Tomasello G, Ghidini M, Liguigli W, Ratti M, Toppo L, Passalacqua R. Targeted therapies in gastric cancer treatment: where we are and where we are going. Investig New Drugs. 2016;34:378–393.CrossRef Tomasello G, Ghidini M, Liguigli W, Ratti M, Toppo L, Passalacqua R. Targeted therapies in gastric cancer treatment: where we are and where we are going. Investig New Drugs. 2016;34:378–393.CrossRef
5.
Zurück zum Zitat Maruyama K, Katai H. Surgical treatment of gastric cancer in Japan, trend from standardization to individualization. Chirurgia (Bucur). 2014;109:722–730. Maruyama K, Katai H. Surgical treatment of gastric cancer in Japan, trend from standardization to individualization. Chirurgia (Bucur). 2014;109:722–730.
6.
Zurück zum Zitat Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39:1010428317714626.PubMed Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39:1010428317714626.PubMed
7.
Zurück zum Zitat Obermannova R, Lordick F. Insights into next developments in advanced gastric cancer. Curr Opin Oncol. 2016;28:367–375.CrossRef Obermannova R, Lordick F. Insights into next developments in advanced gastric cancer. Curr Opin Oncol. 2016;28:367–375.CrossRef
8.
Zurück zum Zitat Hsiao KY, Sun HS, Tsai SJ. Circular RNA—new member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 2017;242:1136–1141.CrossRef Hsiao KY, Sun HS, Tsai SJ. Circular RNA—new member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 2017;242:1136–1141.CrossRef
9.
Zurück zum Zitat Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.CrossRef Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.CrossRef
10.
Zurück zum Zitat Lei B, Tian Z, Fan W, Ni B. Circular RNA: a novel biomarker and therapeutic target for human cancers. Int J Med Sci. 2019;16:292–301.CrossRef Lei B, Tian Z, Fan W, Ni B. Circular RNA: a novel biomarker and therapeutic target for human cancers. Int J Med Sci. 2019;16:292–301.CrossRef
11.
Zurück zum Zitat Lu D, Thum T. RNA-based diagnostic and therapeutic strategies for cardiovascular disease. Nat Rev Cardiol. 2019;16:661–674.CrossRef Lu D, Thum T. RNA-based diagnostic and therapeutic strategies for cardiovascular disease. Nat Rev Cardiol. 2019;16:661–674.CrossRef
12.
Zurück zum Zitat Shan G, Shao B, Liu Q, et al. circFMN2 sponges miR-1238 to promote the expression of LIM-homeobox gene 2 in prostate cancer cells. Mol Ther Nucleic Acids. 2020;21:133–146.CrossRef Shan G, Shao B, Liu Q, et al. circFMN2 sponges miR-1238 to promote the expression of LIM-homeobox gene 2 in prostate cancer cells. Mol Ther Nucleic Acids. 2020;21:133–146.CrossRef
13.
Zurück zum Zitat Chen X, Li HD, Bu FT, et al. Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics. 2020;10:4851–4870.CrossRef Chen X, Li HD, Bu FT, et al. Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics. 2020;10:4851–4870.CrossRef
14.
Zurück zum Zitat Li M, Liu Y, Zhang X, Liu J, Wang P. Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer. Gene. 2018;677:189–197.CrossRef Li M, Liu Y, Zhang X, Liu J, Wang P. Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer. Gene. 2018;677:189–197.CrossRef
15.
Zurück zum Zitat Peng L, Chen G, Zhu Z, et al. Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in Hirschsprung’s disease. Oncotarget. 2017;8:808–818.CrossRef Peng L, Chen G, Zhu Z, et al. Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in Hirschsprung’s disease. Oncotarget. 2017;8:808–818.CrossRef
16.
Zurück zum Zitat Lin J, Liao S, Li E, et al. circCYFIP2 acts as a sponge of miR-1205 and affects the expression of its target gene E2F1 to regulate gastric cancer metastasis. Mol Ther Nucleic Acids. 2020;21:121–132.CrossRef Lin J, Liao S, Li E, et al. circCYFIP2 acts as a sponge of miR-1205 and affects the expression of its target gene E2F1 to regulate gastric cancer metastasis. Mol Ther Nucleic Acids. 2020;21:121–132.CrossRef
17.
Zurück zum Zitat Liu J, Dai X, Guo X, Cheng A, Mac SM, Wang Z. Circ-OXCT1 suppresses gastric cancer EMT and metastasis by attenuating TGF-beta pathway through the Circ-OXCT1/miR-136/SMAD4 Axis. Onco Targets Ther. 2020;13:3987–3998.CrossRef Liu J, Dai X, Guo X, Cheng A, Mac SM, Wang Z. Circ-OXCT1 suppresses gastric cancer EMT and metastasis by attenuating TGF-beta pathway through the Circ-OXCT1/miR-136/SMAD4 Axis. Onco Targets Ther. 2020;13:3987–3998.CrossRef
18.
Zurück zum Zitat Ni WJ, Leng XM. miRNA-dependent activation of mRNA translation. microRNA. 2016;5:83–86.CrossRef Ni WJ, Leng XM. miRNA-dependent activation of mRNA translation. microRNA. 2016;5:83–86.CrossRef
19.
Zurück zum Zitat Afonso-Grunz F, Muller S. Principles of miRNA-mRNA interactions: beyond sequence complementarity. Cell Mol Life Sci. 2015;72:3127–3141.CrossRef Afonso-Grunz F, Muller S. Principles of miRNA-mRNA interactions: beyond sequence complementarity. Cell Mol Life Sci. 2015;72:3127–3141.CrossRef
20.
Zurück zum Zitat Li XW, Yang WH, Xu J. Circular RNA in gastric cancer. Chin Med J Engl. 2020;133:1868–1877.CrossRef Li XW, Yang WH, Xu J. Circular RNA in gastric cancer. Chin Med J Engl. 2020;133:1868–1877.CrossRef
22.
Zurück zum Zitat Liang L, Li L. Down-regulation of circNRIP1 promotes the apoptosis and inhibits the migration and invasion of gastric cancer cells by miR-182/ROCK1 axis. Onco Targets Ther. 2020;13:6279–6288.CrossRef Liang L, Li L. Down-regulation of circNRIP1 promotes the apoptosis and inhibits the migration and invasion of gastric cancer cells by miR-182/ROCK1 axis. Onco Targets Ther. 2020;13:6279–6288.CrossRef
23.
Zurück zum Zitat Zhang Y, Wang M, Zang X, et al. CircHN1 affects cell proliferation and migration in gastric cancer. J Clin Lab Anal. 2020;34:e23433.PubMedPubMedCentral Zhang Y, Wang M, Zang X, et al. CircHN1 affects cell proliferation and migration in gastric cancer. J Clin Lab Anal. 2020;34:e23433.PubMedPubMedCentral
24.
Zurück zum Zitat Xie M, Yu T, Jing X, et al. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation. Mol Cancer. 2020;19:112.CrossRef Xie M, Yu T, Jing X, et al. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation. Mol Cancer. 2020;19:112.CrossRef
25.
Zurück zum Zitat Li H, Yuan H. MiR-1297 negatively regulates metabolic reprogramming in glioblastoma via repressing KPNA2. Hum Cell. 2020;33:619–629.CrossRef Li H, Yuan H. MiR-1297 negatively regulates metabolic reprogramming in glioblastoma via repressing KPNA2. Hum Cell. 2020;33:619–629.CrossRef
26.
Zurück zum Zitat Zhang X, Zhang M, Guo Q, et al. MicroRNA-1297 inhibits proliferation and promotes apoptosis in gastric cancer cells by downregulating CDC6 expression. Anticancer Drugs. 2019;30:803–811.CrossRef Zhang X, Zhang M, Guo Q, et al. MicroRNA-1297 inhibits proliferation and promotes apoptosis in gastric cancer cells by downregulating CDC6 expression. Anticancer Drugs. 2019;30:803–811.CrossRef
27.
Zurück zum Zitat Li J, Gao J, Tian W, Li Y, Zhang J. Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297. Cancer Cell Int. 2017;17:44.CrossRef Li J, Gao J, Tian W, Li Y, Zhang J. Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297. Cancer Cell Int. 2017;17:44.CrossRef
28.
Zurück zum Zitat Sun M, Nie F, Wang Y, et al. LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res. 2016;76:6299–6310.CrossRef Sun M, Nie F, Wang Y, et al. LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res. 2016;76:6299–6310.CrossRef
29.
Zurück zum Zitat Gao W, Cao Y, Guo P, et al. Downregulation of MiR-1297 predicts poor prognosis and enhances gastric cancer cell growth by targeting CREB1. Biomed Pharmacother. 2018;105:413–419.CrossRef Gao W, Cao Y, Guo P, et al. Downregulation of MiR-1297 predicts poor prognosis and enhances gastric cancer cell growth by targeting CREB1. Biomed Pharmacother. 2018;105:413–419.CrossRef
30.
Zurück zum Zitat Thurlings I, de Bruin A. E2F transcription factors control the roller coaster ride of cell cycle gene expression. Methods Mol Biol. 2016;1342:71–88.CrossRef Thurlings I, de Bruin A. E2F transcription factors control the roller coaster ride of cell cycle gene expression. Methods Mol Biol. 2016;1342:71–88.CrossRef
31.
Zurück zum Zitat Adams PD, Kaelin WG Jr. Transcriptional control by E2F. Semin Cancer Biol. 1995;6:99–108.CrossRef Adams PD, Kaelin WG Jr. Transcriptional control by E2F. Semin Cancer Biol. 1995;6:99–108.CrossRef
32.
Zurück zum Zitat Al Ahmed HA, Nada O. E2F3 transcription factor: a promising biomarker in lung cancer. Cancer Biomark. 2017;19:21–26.CrossRef Al Ahmed HA, Nada O. E2F3 transcription factor: a promising biomarker in lung cancer. Cancer Biomark. 2017;19:21–26.CrossRef
33.
Zurück zum Zitat Feng Z, Peng C, Li D, et al. E2F3 promotes cancer growth and is overexpressed through copy number variation in human melanoma. Onco Targets Ther. 2018;11:5303–5313.CrossRef Feng Z, Peng C, Li D, et al. E2F3 promotes cancer growth and is overexpressed through copy number variation in human melanoma. Onco Targets Ther. 2018;11:5303–5313.CrossRef
34.
Zurück zum Zitat Shi L, Zhu H, Shen Y, et al. Regulation of E2F transcription factor 3 by microRNA-152 modulates gastric cancer invasion and metastasis. Cancer Manag Res. 2020;12:1187–1197.CrossRef Shi L, Zhu H, Shen Y, et al. Regulation of E2F transcription factor 3 by microRNA-152 modulates gastric cancer invasion and metastasis. Cancer Manag Res. 2020;12:1187–1197.CrossRef
35.
Zurück zum Zitat Liang C, Yue C, Liang C, et al. The long non-coding RNA SBF2-AS1 exerts oncogenic functions in gastric cancer by targeting the miR-302b-3p/E2F transcription factor 3 axis. Onco Targets Ther. 2019;12:8879–8893.CrossRef Liang C, Yue C, Liang C, et al. The long non-coding RNA SBF2-AS1 exerts oncogenic functions in gastric cancer by targeting the miR-302b-3p/E2F transcription factor 3 axis. Onco Targets Ther. 2019;12:8879–8893.CrossRef
36.
Zurück zum Zitat Yang H, Wang L, Tang X, Bai W. miR-203a suppresses cell proliferation by targeting E2F transcription factor 3 in human gastric cancer. Oncol Lett. 2017;14:7687–7690.PubMedPubMedCentral Yang H, Wang L, Tang X, Bai W. miR-203a suppresses cell proliferation by targeting E2F transcription factor 3 in human gastric cancer. Oncol Lett. 2017;14:7687–7690.PubMedPubMedCentral
Metadaten
Titel
Circ_PGPEP1 Serves as a Sponge of miR-1297 to Promote Gastric Cancer Progression via Regulating E2F3
verfasst von
Yingxin Wang
Xia Liu
Liwei Wang
Zhenduo Zhang
Zhong Li
Ming Li
Publikationsdatum
01.01.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2021
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06783-5

Weitere Artikel der Ausgabe 12/2021

Digestive Diseases and Sciences 12/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.